Halopemide

CAS No. 59831-65-1

Halopemide( —— )

Catalog No. M26708 CAS No. 59831-65-1

Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 Get Quote
10MG 192 Get Quote
25MG 385 Get Quote
50MG 575 Get Quote
100MG 801 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Halopemide
  • Note
    Research use only, not for human use.
  • Brief Description
    Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.
  • Description
    Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.(In Vitro):In transdifferentiated MOVAS cells, Halopemide (1-2 μM; 21 days) influences calcification.(In Vivo):In the majority of monkeys tested, Halopemide (10 mg/kg; p.o.) causes dyskinesias.
  • In Vitro
    Halopemide (1-2 μM; 21 day) affects calcification in transdifferentiated MOVAS cells.
  • In Vivo
    Halopemide (10 mg/kg; p.o.) induces dyskinesias in the majority of monkeys tested.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CDK9
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59831-65-1
  • Formula Weight
    416.88
  • Molecular Formula
    C21H22ClFN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 41.67 mg/mL (99.96 mM)
  • SMILES
    Fc1ccc(cc1)C(=O)NCCN1CCC(CC1)n1c2ccc(Cl)cc2[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sabbah M, et al. Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors. J Med Chem. 2020 May 14;63(9):4749-4761.
molnova catalog
related products
  • Gelsemine

    Gelsemine has marked antinociception in inflammatory, neuropathic and bone cancer pains without inducing antinociceptive tolerance.

  • Fibrin

    Fibrin is the major component of the blood clot and is used for coagulation.Fibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding.?

  • Foxy-5 TFA(881188-51...

    Foxy-5 is a peptide that mimics the WNT5A protein and is expected to reduce the mobility of the cancer cells. Foxy-5 triggers cytosolic free calcium signaling without affecting β-catenin activation and it impairs the migration and invasion of epithelial cancer cells.